Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease

被引:96
作者
Hirayama, T
Sabokbar, A
Itonaga, I
Watt-Smith, S
Athanasou, NA [1 ]
机构
[1] Univ Oxford, Nuffield Orthopaed Ctr, Dept Pathol, Nuffield Dept Orthopaed Surg, Oxford OX3 7LD, England
[2] John Radcliffe Hosp, Dept Oral Surg, Oxford OX3 9DU, England
关键词
Gorham-Stout disease; osteoclast; bone resorption;
D O I
10.1002/path.989
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Gorham-Stout disease (GSD) is a rare, massively osteolytic condition which is associated with increased vascularity and an increase in osteoclast numbers. To determine the cellular and Immoral mechanisms underlying the increase in osteoclast numbers and osteolysis in GSD, this study analysed circulating osteoclast precursor numbers and sensitivity to osteoclastogenic factors in a GSD patient and age/sex-matched controls. Monocytes were cultured with NI-CSF (25 ng/ml) and RANKL (30 ng/ml) and osteoclast formation was assessed in terms of the formation of TRAP(+) and VNR+ multinucleated cells and the extent of lacunar resorption. There was no increase in the proportion of circulating osteoclast precursors in GSD relative to controls, but lacunar resorption was consistently greater in GSD monocyte cultures. Increased osteoclast formation in GSD was noted when monocytes were incubated with IL-1 beta (I m/ml), IL-6/sIL-6R (100 ng/ml), and TNF alpha (10 ng/ml). An increase in osteoclast differentiation and bone resorption was also noted in control monocyte cultures in the presence of GSD serum. These results indicate that the increase in osteoclast formation in GSD is due not to an increase in the number of circulating osteoclast precursors, but rather to an increase in the sensitivity of these precursors to Immoral factors which promote osteoclast formation and bone resorption. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:624 / 630
页数:7
相关论文
共 22 条
[1]
Andersson Goran, 1992, P55
[2]
Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors [J].
Arai, F ;
Miyamoto, T ;
Ohneda, O ;
Inada, T ;
Sudo, T ;
Brasel, K ;
Miyata, T ;
Anderson, DM ;
Suda, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (12) :1741-1754
[4]
BARON R, 1986, AM J PATHOL, V122, P363
[5]
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts [J].
Burgess, TL ;
Qian, YX ;
Kaufman, S ;
Ring, BD ;
Van, G ;
Capparelli, C ;
Kelley, M ;
Hsu, HL ;
Boyle, WJ ;
Dunstan, CR ;
Hu, S ;
Lacey, DL .
JOURNAL OF CELL BIOLOGY, 1999, 145 (03) :527-538
[6]
GORHAMS SYNDROME - A CASE-REPORT AND REVIEW OF THE LITERATURE [J].
CHOMA, ND ;
BISCOTTI, CV ;
BAUER, TW ;
MEHTA, AC ;
LICATA, AA .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (06) :1151-1156
[7]
Collin-Osdoby PA, 2000, J BONE MINER RES, V15, pS219
[8]
Interleukin-6: A potential mediator of the massive osteolysis in patients with Gorham-Stout disease [J].
Devlin, RD ;
Bone, HG ;
Roodman, GD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) :1893-1897
[9]
The human osteoclast precursor circulates in the monocyte fraction [J].
Fujikawa, Y ;
Quinn, JMW ;
Sabokbar, A ;
McGee, JO ;
Athanasou, NA .
ENDOCRINOLOGY, 1996, 137 (09) :4058-4060
[10]
MASSIVE OSTEOLYSIS (ACUTE SPONTANEOUS ABSORPTION OF BONE, PHANTOM BONE, DISAPPEARING BONE) - ITS RELATION TO HEMANGIOMATOSIS [J].
GORHAM, LW ;
STOUT, AP .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1955, 37 (05) :985-1004